Page last updated: 2024-10-30

loxoprofen and Disease Exacerbation

loxoprofen has been researched along with Disease Exacerbation in 1 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Research Excerpts

ExcerptRelevanceReference
"Knee pain was assessed by weight distribution on the hind paw, and cartilage damage and MMP production in the joints were evaluated 18 days after surgery."1.36High molecular weight hyaluronic acid relieved joint pain and prevented the progression of cartilage degeneration in a rabbit osteoarthritis model after onset of arthritis. ( Hashizume, M; Koike, N; Mihara, M; Suzuki, M; Yoshida, H, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashizume, M1
Koike, N1
Yoshida, H1
Suzuki, M1
Mihara, M1

Other Studies

1 other study available for loxoprofen and Disease Exacerbation

ArticleYear
High molecular weight hyaluronic acid relieved joint pain and prevented the progression of cartilage degeneration in a rabbit osteoarthritis model after onset of arthritis.
    Modern rheumatology, 2010, Volume: 20, Issue:5

    Topics: Adjuvants, Immunologic; Analgesics; Animals; Animals, Inbred Strains; Anti-Inflammatory Agents, Non-

2010